Loading...

BYND

BYS

BEYONDSPRING INC

(BYSI)

2024 6-K

Show Summary

Summary

Financial Results Announcement

13 Aug '25

Investor Meetings

3 Jul '25

Financial Statements

12 May '25

Financial Results

27 Mar '25

Asset Sale Completion

25 Feb '25

Share Purchase Agreement

28 Jan '25

Domestic Filer Status

3 Jan '25

Financial Results Announcement

29 Aug '24

Collaboration Announcement

6 Aug '24

Share Issuance

12 Jun '24

Management Change

18 Mar '24

Nasdaq Notification

26 Feb '24

Financial Results Report

2 Feb '24

Arbitration Award

16 Jan '24

Accountant Change

10 Jan '24

External Links:

SEC

On January 10, 2024, BeyondSpring Inc. announced that an arbitration tribunal rejected all claims made by Jiangsu Hengrui Pharmaceuticals against its Chinese subsidiary, Dalian Wanchunbulin. This filing builds on a previous report from September 20, 2023, about the ongoing arbitration.

AI Assistant

BEYONDSPRING INC

2024

6 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.